Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 23969695)

1.

β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

Cannavo A, Rengo G, Liccardo D, Pagano G, Zincarelli C, De Angelis MC, Puglia R, Di Pietro E, Rabinowitz JE, Barone MV, Cirillo P, Trimarco B, Palmer TM, Ferrara N, Koch WJ, Leosco D, Rapacciuolo A.

Circulation. 2013 Oct 8;128(15):1612-22. doi: 10.1161/CIRCULATIONAHA.113.002659. Epub 2013 Aug 22.

2.

MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade.

Castaldi A, Zaglia T, Di Mauro V, Carullo P, Viggiani G, Borile G, Di Stefano B, Schiattarella GG, Gualazzi MG, Elia L, Stirparo GG, Colorito ML, Pironti G, Kunderfranco P, Esposito G, Bang ML, Mongillo M, Condorelli G, Catalucci D.

Circ Res. 2014 Jul 7;115(2):273-83. doi: 10.1161/CIRCRESAHA.115.303252. Epub 2014 May 7.

3.

Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, Sasaki T, Irie-Sasaki J, Gidrewicz D, Rybin VO, Wada T, Steinberg SF, Backx PH, Penninger JM.

Circulation. 2003 Oct 28;108(17):2147-52. Epub 2003 Sep 8.

4.
5.

The beta-adrenergic receptors.

Wallukat G.

Herz. 2002 Nov;27(7):683-90. Review.

PMID:
12439640
6.

S49G and R389G polymorphisms of the β₁-adrenergic receptor influence signaling via the cAMP-PKA and ERK pathways.

Zhang F, Steinberg SF.

Physiol Genomics. 2013 Dec 1;45(23):1186-92. doi: 10.1152/physiolgenomics.00087.2013. Epub 2013 Oct 22.

7.

Chronic partial unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts.

Wang J, Tsukashita M, Nishina T, Marui A, Yoshikawa E, Muranaka H, Matsuoka S, Ikeda T.

J Thorac Cardiovasc Surg. 2009 Feb;137(2):465-70. doi: 10.1016/j.jtcvs.2008.08.033. Epub 2008 Dec 19.

PMID:
19185171
8.
9.

Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.

Zheng M, Han QD, Xiao RP.

Sheng Li Xue Bao. 2004 Feb 25;56(1):1-15. Review.

10.

Restoration of myocardial beta-adrenergic receptor signaling after left ventricular assist device support.

Pandalai PK, Bulcao CF, Merrill WH, Akhter SA.

J Thorac Cardiovasc Surg. 2006 May;131(5):975-80.

PMID:
16678578
11.

Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling.

Zhang X, Szeto C, Gao E, Tang M, Jin J, Fu Q, Makarewich C, Ai X, Li Y, Tang A, Wang J, Gao H, Wang F, Ge XJ, Kunapuli SP, Zhou L, Zeng C, Xiang KY, Chen X.

Circ Res. 2013 Feb 1;112(3):498-509. doi: 10.1161/CIRCRESAHA.112.273896. Epub 2012 Oct 25.

12.

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.

Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Aug 10;110(6):692-9. Epub 2004 Jul 19.

13.

Analysis of domain responsible for desensitization of beta1-adrenergic receptor.

Akiyama C, Nagao T, Kurose H.

Jpn J Pharmacol. 1999 Sep;81(1):12-20.

14.

Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction.

Yoo B, Lemaire A, Mangmool S, Wolf MJ, Curcio A, Mao L, Rockman HA.

Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1377-86. doi: 10.1152/ajpheart.00504.2009. Epub 2009 Jul 24.

15.

Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice.

Engelhardt S, Hein L, Wiesmann F, Lohse MJ.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):7059-64.

16.

Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor.

Adams JW, Wang J, Davis JR, Liaw C, Gaidarov I, Gatlin J, Dalton ND, Gu Y, Ross J Jr, Behan D, Chien K, Connolly D.

Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H509-21. doi: 10.1152/ajpheart.00368.2008. Epub 2008 Jun 6.

17.
18.

Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.

Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE, Koch WJ.

Circulation. 2009 Jan 6;119(1):89-98. doi: 10.1161/CIRCULATIONAHA.108.803999. Epub 2008 Dec 22.

19.

β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro.

Hakalahti AE, Khan H, Vierimaa MM, Pekkala EH, Lackman JJ, Ulvila J, Kerkelä R, Petäjä-Repo UE.

Mol Pharmacol. 2013 Jan;83(1):129-41. doi: 10.1124/mol.112.080440. Epub 2012 Oct 11.

20.

Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1).

Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, Seeland U, Schlüter KD, Böhm M.

Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H1253-62.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk